戻る Agenda
Session 1: Manufacturing and Supply – Ensuring Patients’ Access
Session Chair(s)
Yvonne Stewart, PhD
Head of Brexit Implementation, Office of the CEO and CFO
GSK, United Kingdom
Speaker(s)
Industry Case Example: Putting Brexit Supply Impact in a Global Perspective
Elizabeth Kuiper, MA
European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium
Executive Director, Public Affairs
UK Third Country Scenario Implications on Supply
Gerald W. Heddell
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Director, Inspection Enforcement & Standards Division
A National Member State’s Perspective
Paul Sexton
Health Products Regulatory Authority (HPRA), Ireland
GMP Manager